VA
Biden Cancer Moonshot Announces New Initiatives to Improve Diagnosis, Precision Treatments
The program announced a series of new public and private initiatives and projects designed to support its stated goal of halving the cancer death rate over the next 25 years.
VA Offering No-Cost PGx Testing Through End of 2025
The program will be rolled out within Veterans Integrated Service Network 4 facilities, which served more than 300,000 patients last year.
BioAffinity Technologies' Lung Cancer Test Added to Federal Supply Schedule
The laboratory-developed test analyzes self-collected sputum samples treated with a fluorescent compound.
Foundation Medicine Nabs Five-Year VA Contract for Tumor Molecular Profiling of Cancer Patients
The national contract covers FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne RNA, and FoundationOne Heme.
VA Aims to Automate Input of Pharmacogenomic Data Into EHR, Studying Impact of Recommendations
Premium
Researchers are taking steps to refine and scale the VA's National Pharmacogenomics Program, an extension of the PHASER pilot.
Jan 24, 2024
May 31, 2023
Mar 31, 2023
Jul 11, 2019
Mar 12, 2019